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Abstract
Osteonecrosis of the jaw (ONJ) is an adverse drug reaction described as the progressive destruction and
death of bone that affects the mandible and maxilla of patients exposed to the treatment with
medications known to increase the risk of disease, in the absence of a previous radiation treatment.
Tooth extraction often precedes the manifestation of ONJ; indeed, it is sometimes called trigger event
and it have also been considered as risk factors for the onset of ONJ.
As a consequence, some of the guidelines recommend avoiding tooth extractions in patients at risk of
ONJ; however, a growing body of evidence indicates that dental/periodontal infection prior to extraction,
rather than dental extraction may represent the main local risk factor for ONJ.
Ten patients at risk of ONJ have undergone tooth extractions. They were identified and included in our
retrospective monocentric clinical investigation. 
Patients underwent tooth extractions with standardized procedures (PROMaF protocol), and bone
biopsies were taken.
Extractions were performed due to symptomatic, non-restorable teeth in patient at risk of ONJ;
histological findings of ONJ were observed in all samples.
This outcome may highlight that the proof of non‐exposed ONJ might be the histopathologic confirmation
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of necrotic bone, as stated by European task force on MRONJ. Additionally, alveolar biopsy should




Osteonecrosis of the jaw (ONJ) is an adverse drug reaction described as the progressive destruction and
death of bone that affects the mandible and maxilla of patients exposed to the treatment with medications
known to increase the risk of disease, in the absence of a previous radiation treatment[1][2].
Several risk factors have been associated with increased likelihood of ONJ development, including
systemic, drug-related and oral risk factors[2][3][4]. Among ONJ risk factors, tooth extraction have been
described as one of the major risk factors for the onset of ONJ; indeed, it is considered a potential trigger
for ONJ[2][3][4].
As a consequence, some of the guidelines recommend avoiding tooth extractions in patients at risk of ONJ;
however, a growing body of evidence indicates that dental/periodontal infection prior to extraction, rather
than dental extraction may represent the main local risk factor for ONJ[5].
The aim of this retrospective study was to assess the histology of the alveolar bone of cancer patients that
underwent dental extractions.
 
Materials and Methods: 
Study Design
A retrospective monocentric hospital-based study on cancer patients attending the Unit of Oral Medicine of
the Paolo Giaccone Policlinico University Hospital in Palermo (Italy) was performed. The study is in
accordance with the 2013 Declaration of Helsinki and has been approved by the standing ethical
committee of the Paolo Giaccone Policlinico University Hospital in Palermo (Italy). 
After clinical and radiological examination, tooth extraction was recommended as the necessary treatment
of choice in all cases[2]. A standardized medical-surgical protocol for dental extraction application was
applied to all patients enrolled. Before surgical procedures, all patients signed written informed consent.
 
Entry and Exclusion Criteria
Patients were eligible for the study if they: (I) were aged >18 years; (II) had treatment with ONJ-related
drugs because of the underlying disease; (III) required tooth extraction (of non-restorable teeth); (IV) had
an absence, at baseline, of unequivocal clinic-radiological signs of ONJ (according to the Italian Societies of
Maxillo-Facial Surgery and of Oral Pathology and Medicine)[2].
Patients were excluded from the study if they: (I) had unequivocal clinical or radiological signs of ONJ in the
surgical area; (II) had a previous history of irradiation to the head and neck area; (III) had neoplastic
involvement of the jaws; (IV) were in poor general condition; (V) were pregnant or breast-feeding women.
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Clinical and Surgical Procedures
During the first visit, medical, pharmacological, and dental histories of patients were recorded.
All patients underwent peri-operative pharmacological treatment, based on the administration of
amoxicillin/clavulanate potassium and metronidazole, and the use of antiseptic (chlorhexidine 0,2%
mouthwashes) (as previously described[6]).
For all the patients, the surgical protocol included: (1) chlorhexidine 0.2% mouthwash 30 mL swished up to
60 s; (2) local anaesthesia, achieved using 3% mepivacaine hydrochloride without adrenaline; (3) elevation
of a full-thickness mucoperiosteal flap; (4) tooth luxation and avulsion; (5) alveolar bone specimen
collection (preferably from the interradicular septum); (6) debridement of the post-extraction socket and
osteoplasty by means of an ultrasonic surgical device (Mectron Piezosurgery Device®, Mectron Medical




Specimens were evaluated as previously described by Nicolatou-Galitis et al.[5] The assessment of the
glass slides was performed by a general pathologist, who is specialized in oral diseases. 
 
Statistical Analysis 
The statistical units are the patients who satisfy the inclusion criteria of the study. Descriptive statistics of
all data were conventionally calculated.
 
Results: 
Ten cancer patients completed the protocol and were available for the analysis. They were mostly males
(60%), with a mean age 66 ± 14 years. Multiple myeloma was the most common diagnosis (30%), followed
by lung (20%) and breast cancer (20%).
Overall, the mean duration of ONJ-related medication was 13.3 ± 5.3 months. In detail, denosumab was
administered to 5 (50%), the mean duration of therapy was 13.6 ± 6.6 months. Zoledronate was
administered to 4 of them (40%), the mean duration of therapy was 13.3 ± 4 months. Bevacizumab was
administered to the last patient, the duration of the therapy was 12 months. 
Thirteen tooth extractions were made: eight extractions (61.5%) were from the maxilla and five (38,5%)
from the mandible. Most of the extracted teeth were molars (84,6%). Dental extraction was indicated for 7
teeth due to Miller degree 3 mobility; five teeth were extracted because of large carious lesions that could
not be treated conservatively; two teeth were extracted for pericoronitis.
Histological findings of ONJ were observed in all harvested samples.
 
Conclusions.: 
Qeios, CC-BY 4.0   ·   Article, May 29, 2021
Qeios ID: JK459H.2   ·   https://doi.org/10.32388/JK459H.2 3/4
This outcome may highlight that the proof of non‐exposed ONJ might be the histopathologic confirmation of
necrotic bone, as stated by European task force on MRONJ[7]. Additionally, alveolar biopsy should possibly
be taken in every case of suspected ONJ, which needs a proper and prompt management for successful
healing.
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